SIMONE, Isabella Laura
 Distribuzione geografica
Continente #
NA - Nord America 11.903
AS - Asia 4.422
EU - Europa 2.770
SA - Sud America 1.102
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 20.356
Nazione #
US - Stati Uniti d'America 11.787
SG - Singapore 1.694
HK - Hong Kong 1.062
CN - Cina 1.042
BR - Brasile 963
SE - Svezia 533
IT - Italia 413
DE - Germania 386
RU - Federazione Russa 386
UA - Ucraina 339
VN - Vietnam 235
FI - Finlandia 223
GB - Regno Unito 189
IN - India 90
FR - Francia 89
CI - Costa d'Avorio 68
CA - Canada 60
AR - Argentina 56
BD - Bangladesh 49
IQ - Iraq 39
BE - Belgio 37
ID - Indonesia 37
MX - Messico 31
IE - Irlanda 29
PL - Polonia 27
ZA - Sudafrica 26
EC - Ecuador 25
TR - Turchia 24
AT - Austria 23
JP - Giappone 23
ES - Italia 22
AE - Emirati Arabi Uniti 19
UZ - Uzbekistan 19
NL - Olanda 18
LT - Lituania 16
VE - Venezuela 13
UY - Uruguay 12
JO - Giordania 10
MA - Marocco 10
SA - Arabia Saudita 10
PK - Pakistan 9
CO - Colombia 8
PY - Paraguay 8
AZ - Azerbaigian 7
EU - Europa 7
KE - Kenya 7
MY - Malesia 7
PE - Perù 7
AU - Australia 6
BG - Bulgaria 6
EG - Egitto 6
IL - Israele 6
IR - Iran 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
JM - Giamaica 5
RO - Romania 5
TN - Tunisia 5
CL - Cile 4
CR - Costa Rica 4
GE - Georgia 4
KR - Corea 4
LV - Lettonia 4
NP - Nepal 4
TW - Taiwan 4
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
Totale 20.344
Città #
Fairfield 1.523
Woodbridge 1.170
Ashburn 1.059
Chandler 901
Singapore 833
Houston 797
Jacksonville 783
Seattle 635
Hong Kong 589
Wilmington 558
Cambridge 529
Ann Arbor 487
Nyköping 369
Beijing 271
Roxbury 224
Lawrence 223
New York 190
Nanjing 179
Boardman 154
Des Moines 149
Los Angeles 104
Dallas 100
Bari 96
Princeton 93
Ho Chi Minh City 78
San Diego 75
Abidjan 68
Santa Clara 64
Brooklyn 63
Nanchang 63
Munich 61
São Paulo 61
Inglewood 60
Hebei 55
Dearborn 51
Jiaxing 50
Shenyang 48
Buffalo 46
London 44
Hanoi 39
Tianjin 39
Falls Church 38
Brussels 37
Rio de Janeiro 37
Dong Ket 36
Belo Horizonte 34
Marseille 30
Paris 30
Dublin 29
Changsha 28
Norwalk 28
Jakarta 27
Moscow 25
Redwood City 24
Council Bluffs 23
Guangzhou 23
Pune 22
Tokyo 21
Nuremberg 20
Warsaw 20
Columbus 19
The Dalles 19
Curitiba 18
Helsinki 18
Brasília 17
Frankfurt am Main 17
Tashkent 17
Turin 17
San Francisco 16
Boston 15
Milan 15
Stockholm 15
Taranto 15
Baghdad 14
Chennai 14
Chicago 14
Rome 14
Shanghai 14
Campinas 13
Johannesburg 13
Washington 13
Jinan 12
Montreal 12
San Mateo 12
Toronto 12
Indiana 11
Kunming 11
Leawood 11
Zhengzhou 11
Amsterdam 10
Auburn Hills 10
Denver 10
Monmouth Junction 10
Phoenix 10
Quito 10
Ribeirão Preto 10
Salt Lake City 10
Vienna 10
Amman 9
Atlanta 9
Totale 14.040
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 639
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 188
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 185
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 166
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 162
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 161
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 159
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 158
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 157
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 155
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 144
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 141
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 140
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 135
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 133
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 129
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 128
Multiparametric unconventional MRI study in early stage of ALS disease 127
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 125
Intrathecal immune response in human immunodeficiency virus infection 122
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 122
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 122
The role of imaging in Hirayama disease 122
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 121
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 120
Hirayama disease: the importance of an early diagnosis 120
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 119
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 118
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 118
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 113
HFE p.H63D polymorphism does not influence ALS phenotype and survival 113
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 112
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 110
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 109
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 108
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 106
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 105
Brain cortex thinning in motor and extra-motor areas in amyotrophic lateral sclerosis 104
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. 104
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 103
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 102
null 101
null 100
Brain Cortex Thinning in Motor And Extra-motor Areas in Amyotrophyc Lateral Sclerosis 99
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 99
Verbal Learning Abilities in ALS Patients (P01.109) 99
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 98
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 98
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 97
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 97
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 96
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 95
null 95
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues 95
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 95
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 94
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 94
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 93
Incidence of amyotrophic lateral sclerosis in Europe 92
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 92
BRAIN CORTEX THINNING IN MOTOR AND EXTRA-MOTOR AREAS IN AMYOTROPHIC LATERAL SCLEROSIS 90
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 89
null 88
Prognostic factors in ALS: A critical review 88
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 88
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 86
99mTc-HM-PAO SPET and proton magnetic resonance spectroscopy in patients with ischaemic cerebral infarction 86
null 85
Alzheimer disease: comparison of 99mTc-HMPAO SPET and 1H-MRS data 85
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 85
null 84
null 83
Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients 82
Benign and malignant MS:clinical and 1H-MRS parameters associated with different MS courses 82
dentification of a point mutation impairing the binding between Aquaporin-4 and the Neuromyelitis Optica autoantibodies 81
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 80
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 80
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 79
null 78
null 78
null 78
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. 78
null 78
99Tcm-HMPAO SPET and 1H-MRS (Proton Magnetic Resonance Spectroscopy) in patients with ischaemic cerebral infarction 78
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 78
null 77
null 77
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9 76
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 76
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 76
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy 76
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 76
null 75
Brain cortical thinning in Motor and Extra-motor areas in Amyotrophic Lateral Sclerosis 75
Sintesi intratecale di IgG in corso di infezioni da HIV 75
null 75
null 75
null 75
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). 74
null 74
Totale 10.853
Categoria #
all - tutte 87.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.531 0 0 0 0 0 220 250 169 230 314 190 158
2021/20221.878 55 78 16 37 82 172 46 72 99 110 262 849
2022/20232.261 365 220 157 211 293 255 32 249 393 14 40 32
2023/2024809 57 153 51 39 54 232 21 34 18 21 5 124
2024/20253.356 107 65 322 119 88 285 207 274 173 194 491 1.031
2025/20263.270 1.070 279 410 718 660 133 0 0 0 0 0 0
Totale 21.153